(More on Moderna here: https://www.keionline.org/moderna)
KEI received a letter Dr. Gary Disbrow, the Acting Director of BARDA, just before noon today.
BARDA2KEI.Moderna.Patent.Disclosures.20200903
The BARDA investigation follows the announcement on Saturday that DARPA was also investigating DARPA’s failures to disclose DARPA funding in Moderna patent applications.
This is the BARDA letter.
Knowledge Ecology International
1621 Connecticut Avenue, Suite 500,
Washington, DC 20009
Dear Mr. Love:
Thank you for your recent letter addressing your concerns with transparency and oversight around the Biomedical Advanced Research and Development Authority’s (BARDA) contracts with Moderna in relation to disclosure of federal funding in patents and patent applications.
The contracting officers responsible for the BARDA contracts with Moderna are reviewing the requirements to report the role of government-funding of inventions and identifying any Moderna patents or patent applications that may be associated with BARDA support.
Following this review, BARDA Contracting Officers will be in touch with the company and will ensure Moderna’s compliance with its contractual requirements.
Sincerely,
Gary Disbrow, Ph.D
Acting Director, BARDA
Deputy Assistant Secretary
Office of the Assistant Secretary of Preparedness and Response
Department of Health and Human Services